MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

China Biologic Products Company Profile (NASDAQ:CBPO)

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (?)
Ratings Breakdown: 4 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $116.25 (22.57% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetActions
7/13/2015Deutsche BankInitiated CoverageBuy$149.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015Bank of AmericaInitiated CoverageBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/12/2015Jefferies GroupReiterated RatingBuy$115.00 -> $122.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Jefferies GroupReiterated RatingBuy$57.00 -> $76.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014AegisReiterated RatingBuy$55.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Jefferies GroupReiterated RatingBuy$52.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/8/2014AegisBoost Price TargetBuy$50.00 -> $55.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2014Jefferies GroupInitiated CoverageBuy$52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2014AegisUpgradeBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2014OppenheimerInitiated CoverageOutperform$46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2013AegisDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 9/1/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha